XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Costs and expenses        
Operating costs $ 21,897 $ 6,451 $ 44,413 $ 16,948
Research and development 178 254 731 843
Selling, general and administrative 13,172 14,382 39,725 42,083
Total operating costs and expenses 35,247 21,087 84,869 59,874
Interest expense 10,750 159 14,883 1,197
Interest income (2,117) (1,261) (5,077) (2,031)
Change in fair value of warrants (48,817) 14,884 (17,669) 16,224
Other expense 51 79 526 120
Total other (income) expense (40,133) 13,861 (7,337) 15,510
Net income (loss) $ 4,886 $ (34,948) $ (77,532) $ (75,384)
Earnings (loss) per share        
Basic (in usd per share) $ 0.03 $ (0.21) $ (0.47) $ (0.49)
Diluted (in usd per share) $ 0.00 $ (0.21) $ (0.48) $ (0.49)
Weighted average common shares        
Basic (in shares) 164,018 163,490 163,783 153,513
Diluted (in shares) 165,548 163,490 163,980 153,699
Other comprehensive income (loss)        
Unrealized (loss) gain on debt securities available for sale $ (7) $ 14 $ 634 $ (800)
Total comprehensive income (loss) $ 4,879 $ (34,934) $ (76,898) $ (76,184)